258 related articles for article (PubMed ID: 15519160)
1. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor evaluation of symmetrical 1,5-diamidoanthraquinone derivatives as compared to their disubstituted homologues.
Huang HS; Chiu HF; Tao CW; Chen IB
Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):458-64. PubMed ID: 16595945
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones.
Huang HS; Chou CL; Guo CL; Yuan CL; Lu YC; Shieh FY; Lin JJ
Bioorg Med Chem; 2005 Mar; 13(5):1435-44. PubMed ID: 15698759
[TBL] [Abstract][Full Text] [Related]
5. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
[TBL] [Abstract][Full Text] [Related]
6. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of new 1,5-diazaanthraquinones with cytotoxic activity.
Manzanaro S; Vicent MJ; Martín MJ; Salvador-Tormo N; Pérez JM; del Mar Blanco M; Avendaño C; Menéndez JC; de la Fuente JA
Bioorg Med Chem; 2004 Dec; 12(24):6505-15. PubMed ID: 15556767
[TBL] [Abstract][Full Text] [Related]
8. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ
J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760
[TBL] [Abstract][Full Text] [Related]
9. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
[TBL] [Abstract][Full Text] [Related]
10. NSC746364, NSC746365, and NSC746366: the spectra of cytotoxicity and molecular correlates of response to telomerase activity.
Huang HS; Huang KF; Lee CC; Chen CL; Li CL; Lin JJ
Anticancer Drugs; 2010 Feb; 21(2):169-80. PubMed ID: 19884821
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
12. Cyclopent[a]anthraquinones as DNA intercalating agents with covalent bond formation potential: synthesis and biological activity.
Kim JY; Su TL; Chou TC; Koehler B; Scarborough A; Ouerfelli O; Watanabe KA
J Med Chem; 1996 Jul; 39(14):2812-8. PubMed ID: 8709111
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of 1,5-diazaanthraquinones as antitumour compounds.
Avendaño C; Pérez JM; Blanco Mdel M; de la Fuente JA; Manzanaro S; Vicent MJ; Martín MJ; Salvador-Tormo N; Menéndez JC
Bioorg Med Chem Lett; 2004 Aug; 14(15):3929-32. PubMed ID: 15225700
[TBL] [Abstract][Full Text] [Related]
14. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
Jin GZ; Jin HS; Jin LL
Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2007 Mar; 340(3):147-53. PubMed ID: 17315260
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
19. Bisintercalating threading diacridines: relationships between DNA binding, cytotoxicity, and cell cycle arrest.
Wakelin LP; Bu X; Eleftheriou A; Parmar A; Hayek C; Stewart BW
J Med Chem; 2003 Dec; 46(26):5790-802. PubMed ID: 14667232
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of new anthraquinone derivatives.
Ferrazzi E; Palumbo M; Valisena S; Antonello C; Palù G
Chemioterapia; 1986 Oct; 5(5):330-6. PubMed ID: 3791481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
